Xin Wei, Wang Lin, Lin Jiahui, Wang Yanbu, Pan Qi, Han Yang, Bao Zhiye, Zong Shun, Cheng Ying, Chen Xuchun, Zhao Lin, Li Heran
School of Pharmacy, China Medical University, Shenyang 110122, China.
The First Hospital of China Medical University, Shenyang 110001, China.
Asian J Pharm Sci. 2023 Mar;18(2):100795. doi: 10.1016/j.ajps.2023.100795. Epub 2023 Feb 25.
The weak adhesion between nanocarriers and the intestinal mucosa was one of the main reasons caused the failure in oral delivery. Inspired by the "antiskid tires" with complex chiral patterns, mesoporous silica nanoparticles AT-R@CMSN exhibiting geometrical chiral structure were designed to improve the surface/interface roughness in nanoscale, and employed as the hosting system for insoluble drugs nimesulide (NMS) and ibuprofen (IBU). Once performing the delivery tasks, AT-R@CMSN with rigid skeleton protected the loaded drug and reduced the irritation of drug on gastrointestinal tract (GIT), while their porous structure deprived drug crystal and improved drug release. More importantly, AT-R@CMSN functioned as "antiskid tire" to produce higher friction on intestinal mucosa and substantively influenced multiple biological processes, including "contact", "adhesion", "retention", "permeation" and "uptake", compared to the achiral S@MSN, thereby improving the oral adsorption effectiveness of such drug delivery systems. By engineering AT-R@CMSN to overcome the stability, solubility and permeability bottlenecks of drugs, orally administered NMS or IBU loaded AT-R@CMSN could achieve higher relative bioavailability (705.95% and 444.42%, respectively) and stronger anti-inflammation effect. In addition, AT-R@CMSN displayed favorable biocompatibility and biodegradability. Undoubtedly, the present finding helped to understand the oral adsorption process of nanocarriers, and provided novel insights into the rational design of nanocarriers.
纳米载体与肠黏膜之间的弱黏附力是导致口服给药失败的主要原因之一。受具有复杂手性图案的“防滑轮胎”启发,设计了具有几何手性结构的介孔二氧化硅纳米颗粒AT-R@CMSN,以改善纳米尺度的表面/界面粗糙度,并用作难溶性药物尼美舒利(NMS)和布洛芬(IBU)的载体系统。一旦执行递送任务,具有刚性骨架的AT-R@CMSN可保护负载的药物并减少药物对胃肠道(GIT)的刺激,同时其多孔结构可使药物结晶脱除并改善药物释放。更重要的是,与非手性的S@MSN相比,AT-R@CMSN起到“防滑轮胎”的作用,在肠黏膜上产生更高的摩擦力,并实质性地影响包括“接触”、“黏附”、“滞留”、“渗透”和“摄取”在内的多个生物学过程,从而提高此类药物递送系统的口服吸附效果。通过对AT-R@CMSN进行工程改造以克服药物的稳定性、溶解性和渗透性瓶颈,口服给药的负载NMS或IBU的AT-R@CMSN可实现更高的相对生物利用度(分别为705.95%和444.42%)以及更强的抗炎效果。此外,AT-R@CMSN表现出良好的生物相容性和生物降解性。毫无疑问,本研究结果有助于理解纳米载体的口服吸附过程,并为纳米载体的合理设计提供了新的见解。